ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698269 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698269; 2) Community: the network communities that were significantly associated with the response to NSC 698269; 3) Molecule: the relationships between components within communities and NSC 698269; 4) MDR: the compounds that were significantly associated with the NSC 698269.

NSC Compound Enrichment Correlation
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0487384939331934 -0.070604498
NSC 208734 ACLACINOMYCIN A 0.0487384939331934 -0.1923971
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0487384939331934 -0.014262319
NSC 23936 Null 0.0487384939331934 -0.20383748
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0487384939331934 -0.088183264
NSC 29182 Null 0.0487384939331934 -0.17543981
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0487384939331934 -0.039637609
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0487384939331934 -0.24813871
NSC 373355 Saframycin R 0.0487384939331934 -0.023405131
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0487384939331934 0.031990239
Total:51  Current:41    [First] [Prev] [Next] [Last]